n.a. (ZSPH)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

The Nominees for Best Biopharma CEO of 2015 Are...

The Nominees for Best Biopharma CEO of 2015 Are...

One of these biopharma executives, or the grouped nominees, will win the Swanson Trophy, named in honor of Robert Swanson, Genentech's founding CEO. Here are the best biopharma CEOs.

Why Relypsa Is a New 'Best Idea'

Why Relypsa Is a New 'Best Idea'

It is hard to see the biotech firm not becoming a takeover target.

Biotech Stock Mailbag: Relypsa, Sophiris, Bluebird, Zafgen, NW Bio

Biotech Stock Mailbag: Relypsa, Sophiris, Bluebird, Zafgen, NW Bio

Biotech columnist Adam Feuerstein answers readers' questions about health care.

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZS...

ZS PHARMA, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Merger With AstraZeneca PLC

ZS PHARMA, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Merger With AstraZeneca PLC

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of ZS Pharma, Inc.

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of ZS Pharma, Inc. (ZSPH) Over The Proposed Sale Of The Company To AstraZeneca PLC

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of ZS Pharma, Inc. (ZSPH) Over The Proposed Sale Of The Company To AstraZeneca PLC

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ZS Pharma, Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZS...

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of ZS Pharma, Inc. Of Commencement Of An Investigation In Connection With The Fairness Of The Sale Of The Company To AstraZeneca PLC

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of ZS Pharma, Inc. Of Commencement Of An Investigation In Connection With The Fairness Of The Sale Of The Company To AstraZeneca PLC

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased ZS Pharma, Inc.

ZS Pharma (ZSPH) Stock Gets Rating Downgrade at Credit Suisse

ZS Pharma (ZSPH) Stock Gets Rating Downgrade at Credit Suisse

ZS Pharma (ZSPH) was downgraded to 'neutral' from 'outperform' at Credit Suisse this morning.

ZS Pharma Announces Positive Interim Results From A Long-Term Safety Study Of ZS-9

ZS Pharma Announces Positive Interim Results From A Long-Term Safety Study Of ZS-9

ZS-9 Rapidly Lowered Serum Potassium, Maintained Normokalemia, and Was Well Tolerated for Up to 52 Weeks

Market News: Walt Disney, Qorvo, ZS Pharma

Market News: Walt Disney, Qorvo, ZS Pharma

The stock markets in the United States fluctuated and eventually ended the trading session higher except the S&P 500, down 0.03% today. Sign up for our free newsletter Today, the Department of Lab...

Stocks Are Lower as Chances of December Hike Grow

Stocks Are Lower as Chances of December Hike Grow

Stocks are trading lower Friday as investors try to make sense of a stellar jobs report and what it might mean for the chances of a December rate hike.

3 Big-Volume Stocks You Should Stay Far Away From

3 Big-Volume Stocks You Should Stay Far Away From

These stocks are seeing increased trading volume today. Here's how to trade them now.

ZS Pharma (ZSPH) Stock Skyrockets on AstraZeneca Merger

ZS Pharma (ZSPH) Stock Skyrockets on AstraZeneca Merger

ZS Pharma (ZSPH) stock is spiking in late morning trading on Friday, after the biopharmaceutical company agreed to be acquired by AstraZeneca (AZN) for $2.7 billion.

Market Isn’t Sure What to Make of Blowout Jobs Report

Market Isn’t Sure What to Make of Blowout Jobs Report

Stocks slide as investors hem and haw over whether a blowout jobs report is a good or bad thing.

Relypsa Seen As Next Target After Astra Buys ZS

Relypsa Seen As Next Target After Astra Buys ZS

Shares of ZS Pharma are surging after the development stage drugmaker agreed to be acquired by pharmaceutical giant AstraZeneca in a $2.7B deal.

Stock Futures Struggle for Direction After Blowout Jobs

Stock Futures Struggle for Direction After Blowout Jobs

Stock futures wandered around on Friday in confused trading after the release of a blowout jobs report.

Nov. 6 Premarket Briefing: 10 Things You Should Know

Nov. 6 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are mixed and not moving much as investors gear up for the all-important jobs report Friday morning.

Greek Parliament Approves Reforms Required by Creditors

And four other things you need to know now.

Relypsa Expects Approval Decision Wednesday on Potassium-Lowering Drug

Relypsa Expects Approval Decision Wednesday on Potassium-Lowering Drug

A positive nod from the FDA will prompt Redwood City, Calif-based Relypsa to finalize the hiring of a salesforce and start selling the drug within the next two months.

10 Best Nasdaq Biotech Stocks in the Third Quarter

10 Best Nasdaq Biotech Stocks in the Third Quarter

Here are the 10 stocks in the biotech sector which had the best third-quarter.

First Week of ZSPH November 20th Options Trading

First Week of ZSPH November 20th Options Trading

Investors in ZS Pharma Inc saw new options begin trading this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZSPH options chain for the new November 20th contracts and identified one put and one call contract of particular interest.

Stocks Score Weekly Gains but Days Ahead Could Be Rough

Stocks Score Weekly Gains but Days Ahead Could Be Rough

Wall Street closes the holiday-shortened week with gains, but the week ahead looks to be a rockier road.

Stocks Rise but Energy Selloff Caps Upside

Stocks Rise but Energy Selloff Caps Upside

Stocks are slightly higher by mid-afternoon Friday as a selloff in the energy sector drags on markets.

Stocks Fall as Consumer Sentiment Hits One-Year Low

Stocks Fall as Consumer Sentiment Hits One-Year Low

Stocks remain in the red on Friday after consumer sentiment hits a one-year low in September.